Many researchers find that by the time a person seeks treatment for the symptoms of Alzheimer’s disease, it’s often too late for the available drugs to have an effect. Dr. Adam Boxer’s lab is studying eye movements to try to identify cognitive decline decades before the first symptoms appear.
Summary
- Study Director: Adam Boxer, MD, PhD
- Sponsor: National Institutes of Health (NIH)
- Official Study Title: Eye movement control in normal adults and in adults with neurologic disease
- Conditions Studied: Frontotemporal dementia (FTD), semantic variant primary progressive aphasia (svPPA), nonfluent variant primary progressive aphasia (nfvPPA), Alzheimer’s disease (AD), corticobasal syndrome (CBS), progressive supranuclear palsy (PSP) and healthy adults
Purpose of the Study
The purpose of this study is to learn about the mechanisms of eye movement control and visual perception, as well as how these functions may change with different neurologic diseases.
Study Details
Inclusion Criteria: None
Exclusion Criteria: Subjects are ineligible for portions of our study if they have had cataract surgery in the right eye.
What to Expect
Testing: Subjects view visual stimuli presented on a television monitor while their eye movements are recorded using safe, infrared technology. At times, we may ask questions about some of the pictures shown, and these answers may be recorded.
The Frequency of Visits: One annual visit
Materials Needed Before Evaluation: None
Costs: No costs will be charged for any of the study procedures. Parking will be validated for the 1625 Owens Street Garage or 1630 Third Street Garage at the UCSF Mission Bay campus for all study visits. There is no monetary compensation for participation.
Contact Information
If you are interested in participating in this study or have any questions, please contact the study coordinator, Hilary Heuer, PhD, at [email protected] or 415.476.6743.